Dietary supplementation in patients with alcoholic liver disease: a review on current evidence (Q38920951)

7 September 2017

1 reference

title

Dietary supplementation in patients with alcoholic liver disease: a review on current evidence (English)

1 reference

7 September 2017

alcoholic liver disease

1 reference

Zeinab Ghorbani

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27498574%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Masoomeh Hajizadeh

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27498574%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Azita Hekmatdoost

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27498574%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

language of work or name

1 reference

1 August 2016

1 reference

Hepatobiliary & Pancreatic Diseases International

7 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27498574%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27498574%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

348-360

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27498574%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27498574%20AND%20SRC:MED&resulttype=core&format=json

Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease

1 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

The impact of obesity and metabolic syndrome on alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Pathogenesis of alcoholic liver disease: role of oxidative metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Alcoholic liver disease: pathogenesis and new targets for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Alcoholic liver disease: pathogenesis and new therapeutic targets

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Alcoholic liver disease: pathogenesis, management, and novel targets for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Prevalence and natural history of alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Alcoholic liver disease and malnutrition

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Influence of vitamin E on alcohol-induced changes in antioxidant defenses in mice liver

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Chronic liver inflammation: clinical implications beyond alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

S-adenosyl-L-methionine for alcoholic liver diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Methionine adenosyltransferase and S-adenosylmethionine in alcoholic liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Combined metadoxine and garlic oil treatment efficaciously abrogates alcoholic steatosis and CYP2E1 induction in rat liver with restoration of AMPK activity

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Ascorbic acid suppresses endotoxemia and NF-κB signaling cascade in alcoholic liver fibrosis in guinea pigs: a mechanistic approach

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Common polymorphism in the PNPLA3/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Variant in PNPLA3 is associated with alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

New advances in molecular mechanisms and emerging therapeutic targets in alcoholic liver diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Nutrition in alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Blood antioxidant levels in patients with alcoholic liver disease correlate with the degree of liver impairment and are not specific to alcoholic liver injury itself

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Carotenoid lutein protects rats from paracetamol-, carbon tetrachloride- and ethanol-induced hepatic damage

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Luteolin alleviates alcoholic liver disease induced by chronic and binge ethanol feeding in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Effects of beta-carotene on antioxidant status in rats with chronic alcohol consumption.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Effect of beta-carotene supplementation on rats submitted to chronic ethanol ingestion

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Interactions between alcohol and beta-carotene in patients with alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Independent antioxidant action of vitamins E and C in cultured rat hepatocytes intoxicated with allyl alcohol

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Ascorbic acid supplementation down-regulates the alcohol induced oxidative stress, hepatic stellate cell activation, cytotoxicity and mRNA levels of selected fibrotic genes in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Vitamin C protective role for alcoholic liver disease in mice through regulating iron metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Chronic ethanol and cocaine-induced hepatotoxicity: effects of vitamin E supplementation.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Protective effects of antioxidant raxofelast in alcohol-induced liver disease in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

A randomized placebo controlled trial of vitamin E for alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Bone changes in alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Alcoholic liver disease and changes in bone mineral density

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Vitamin D deficiency in cirrhosis relates to liver dysfunction rather than aetiology.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Severe Vitamin D Deficiency May be an Additional Cofactor for the Occurrence of Alcoholic Steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

The effect of a single oral megadose of vitamin D provided as either ergocalciferol (D2) or cholecalciferol (D3) in alcoholic liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Dietary nicotinic acid supplementation ameliorates chronic alcohol-induced fatty liver in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Antifibrotic effect of silymarin in rat secondary biliary fibrosis is mediated by downregulation of procollagen alpha1(I) and TIMP-1

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Silymarin Retards the Progression of Alcohol-Induced Hepatic Fibrosis in Baboons

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Prevention of alloxan-induced diabetes mellitus in the rat by silymarin

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Silibinin (Milk Thistle) potentiates ethanol-dependent hepatocellular carcinoma progression in male mice

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

An updated systematic review with meta-analysis for the clinical evidence of silymarin

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Anti-hyperglycemic and insulin sensitizer effects of turmeric and its principle constituent curcumin

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Curcumin prevents chronic alcohol-induced liver disease involving decreasing ROS generation and enhancing antioxidative capacity.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Effect of resveratrol on alcohol-induced mortality and liver lesions in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Resveratrol, a red wine polyphenol, attenuates ethanol-induced oxidative stress in rat liver.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Resveratrol alleviates alcoholic fatty liver in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

The resveratrol attenuates ethanol-induced hepatocyte apoptosis via inhibiting ER-related caspase-12 activation and PDE activity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Trans-resveratrol alone and hydroxystilbenes of rhubarb (Rheum rhaponticum L.) root reduce liver damage induced by chronic ethanol administration: a comparative study in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Enzymatic modification enhances the protective activity of citrus flavonoids against alcohol-induced liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Narirutin fraction from citrus peels attenuates alcoholic liver disease in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Gut microbiota in alcoholic liver disease: pathogenetic role and therapeutic perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Probiotics (Lactobacillus rhamnosus R0011 and acidophilus R0052) reduce the expression of toll-like receptor 4 in mice with alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Recent advances in dietary supplementation, in treating non-alcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Effects of Korean Red Ginseng (Panax ginseng), urushiol (Rhus vernicifera Stokes), and probiotics (Lactobacillus rhamnosus R0011 and Lactobacillus acidophilus R0052) on the gut-liver axis of alcoholic liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Efficiency of double layered microencapsulated probiotic to modulate proinflammatory molecular markers for the management of alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Oral administration of heat-killed Lactobacillus brevis SBC8803 ameliorates alcoholic liver disease in ethanol-containing diet-fed C57BL/6N mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Inhibition of miR122a by Lactobacillus rhamnosus GG culture supernatant increases intestinal occludin expression and protects mice from alcoholic liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Zinc absorption in alcoholics using zinc-65

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Zinc absorption and leukocyte zinc in alcoholic and nonalcoholic cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Hepatic zinc content in patients with various stages of alcoholic liver disease and in patients with chronic active and chronic persistent hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Zinc Depletion in Alcoholic Liver Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Zinc metabolism in alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Zinc, copper, manganese, and iron in chronic alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Dietary zinc deficiency exaggerates ethanol-induced liver injury in mice: involvement of intrahepatic and extrahepatic factors

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Preservation of intestinal structural integrity by zinc is independent of metallothionein in alcohol-intoxicated mice

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Prevention of alterations in intestinal permeability is involved in zinc inhibition of acute ethanol-induced liver damage in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Zinc supplementation prevents alcoholic liver injury in mice through attenuation of oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Metallothionein-independent zinc protection from alcoholic liver injury

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Zinc supplementation reverses alcohol-induced steatosis in mice through reactivating hepatocyte nuclear factor-4alpha and peroxisome proliferator-activated receptor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Suppression of Fas-mediated signaling pathway is involved in zinc inhibition of ethanol-induced liver apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Role of S-adenosyl-L-methionine in the treatment of alcoholic liver disease: introduction and summary of the symposium

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Folate deficiency, methionine metabolism, and alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Role of abnormal methionine metabolism in alcoholic liver injury

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Vitamin-dependent methionine metabolism and alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease: summary of a symposium

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Alleviation of alcoholic liver injury by betaine involves an enhancement of antioxidant defense via regulation of sulfur amino acid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Effects of oral S-adenosyl-L-methionine on hepatic glutathione in patients with liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

S-adenosyl-L-methionine treatment for alcoholic liver disease: a double-blinded, randomized, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

B-Vitamin dependent methionine metabolism and alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Transcriptome analysis of garlic-induced hepatoprotection against alcoholic fatty liver.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

The mechanism of the hypolipidemic effect of garlic oil extract in rats fed on high sucrose and alcohol diets.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Garlic oil alleviated ethanol-induced fat accumulation via modulation of SREBP-1, PPAR-α, and CYP2E1.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Could garlic partially-counteract excess alcohol consumption? A postulated role of garlic oil in prevention of ethanol-induced hepatotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

The anti-fatty liver effects of garlic oil on acute ethanol-exposed mice

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Effect of garlic oil extract on glutathione reductase levels in rats fed on high sucrose and alcohol diets: a possible mechanism of the activity of the oil

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Hepatoprotective effect of aged black garlic on chronic alcohol-induced liver injury in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Ameliorative effects of soy 11S protein on liver damage and hyperlipidemia in alcohol-fed rats

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Effects of soy protein on alcoholic liver disease in rats undergoing ethanol withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Nutritional therapy in cirrhosis or alcoholic hepatitis: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

ESPEN Guidelines on Enteral Nutrition: Liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

Normal protein diet for episodic hepatic encephalopathy: results of a randomized study.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2816%2960096-6

7 January 2021

10.1016/S1499-3872(16)60096-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27498574%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1 reference